<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001639'>Hypertrophic cardiomyopathy</z:hpo> (HCM) is characterized by inappropriate <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> (LVH) in the setting of a nondilated left ventricle </plain></SENT>
<SENT sid="1" pm="."><plain>HCM is often associated with asymmetric LVH, a family history of HCM, sarcomeric genetic mutations, and an increased risk of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>There is a wide clinical variability in HCM presenting during childhood and a relative lack of data on the pediatric population </plain></SENT>
<SENT sid="3" pm="."><plain>This review will cover HCM presenting in infancy, childhood, and adolescence </plain></SENT>
</text></document>